A Single-dose, Open Design Study to Evaluate The Pharmacokinetics of HR17031 Injection With Renal Insufficiency
Latest Information Update: 07 Mar 2024
At a glance
- Drugs HR 17031 (Primary)
- Indications Renal failure
- Focus Pharmacokinetics
- Sponsors Jiangsu Hengrui Medicine Co.
- 28 Mar 2022 New trial record